Skip to main navigation Skip to search Skip to main content

Assessment of liver fibrosis in drug and alcohol units for prioritizing the treatment of HCV infection.

Project Details

StatusFinished
Effective start/end date1/01/18 → 31/12/19

Funding

  • Gilead Sciences S.L: €41,954.00